News

Albireo Reports First Quarter 2017 Financial Results

BOSTON, May 10, 2017 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today reported its financial results for the first quarter ended March 31, 2017.

2017-06-27T12:04:35+00:00